| Dose-related Myelosuppression. Discontinue if Blood Counts decrease substantially. Discontinue if Toxic Hepatitis, Biliary Stasis, Clinical Jaundice or decreased LFT develop. Establish adequate diagnosis of the disease prior to initiating Therapy. Advise patients (women) to use reliable contraceptive measures during therapy |